Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 2;15(3):962. doi: 10.3390/cancers15030962

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Propensity of survival without attrition in respect to stem cell transplantation, (a) maintenance, (b) and remission status (c). This figure presents follow-up in years and propensity of survival without attrition. On the top, patients with performed transplantation (SCT) in the first LoT are presented in comparison to transplant ineligible patients (No SCT). In the middle the difference in propensity of survival without attrition is displayed comparing patients with and without maintenance in frontline treatment. In the last diagram the propensity of survival without attrition is presented comparing patients in different remission status after the first LoT. Very good partial responses or better are presented (VGPR) in one group. Patients with partial response (PR), minimal response (MR) and stable disease (SD) are categorised in another group. Patients with progressive disease (PD) are presented separately from patients without noted remission status (n.a.).

Propensity of survival without attrition in respect to stem cell transplantation, (a) maintenance, (b) and remission status (c). This figure presents follow-up in years and propensity of survival without attrition. On the top, patients with performed transplantation (SCT) in the first LoT are presented in comparison to transplant ineligible patients (No SCT). In the middle the difference in propensity of survival without attrition is displayed comparing patients with and without maintenance in frontline treatment. In the last diagram the propensity of survival without attrition is presented comparing patients in different remission status after the first LoT. Very good partial responses or better are presented (VGPR) in one group. Patients with partial response (PR), minimal response (MR) and stable disease (SD) are categorised in another group. Patients with progressive disease (PD) are presented separately from patients without noted remission status (n.a.).